IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#923
Positioning
Market Dominance
Services
Healthcare
$4.5B
John C. Rademacher
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures. It also offers treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy.
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
X-AXIS: EV/EBITDA (LOWER = CHEAPER) | Y-AXIS: ROE (HIGHER = ELITE) | RED CIRCLE = OPCH ANALYSIS TARGET
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$YALA Yalla Group Ltd | 75 | 89 | 99 | 80 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$GRVY GRAVITY Co., Ltd. | 75 | 82 | 96 | 71 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$ISSC INNOVATIVE SOLUTIONS & SUPPORT INC | 73 | 81 | 88 | 94 | 25.0x | 14.1x | 17.1% | 10.3% | 35.5% | 14.6% | 10.1% | 105.2% | 0.0% | 41.0x | $244M | VS | |
$AER AerCap Holdings N.V. | 72 | 60 | 87 | 84 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$HCSG HEALTHCARE SERVICES GROUP INC | 72 | 74 | 88 | 88 | 7.1x | 6.1x | 28.9% | 20.8% | 20.8% | 9.9% | 9.3% | 8.5% | 0.0% | 1.0x | $1.2B | VS | |
$LQDT LIQUIDITY SERVICES INC | 72 | 90 | 88 | 68 | 24.9x | 14.3x | 14.1% | 8.3% | 45.7% | 8.5% | 6.2% | 28.1% | 0.0% | 0.0x | $736M | VS | |
$TRTNpA Triton International Ltd | 71 | 70 | 89 | 70 | - | 1.7x | 0.0% | - | 97.4% | 58.0% | 37.4% | - | 8.8% | 264.0x | $2.5B | VS | |
$EDU New Oriental Education & Technology Group Inc. | 71 | 83 | 52 | 77 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$NTES NetEase, Inc. | 71 | 88 | 93 | 68 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$UTI UNIVERSAL TECHNICAL INSTITUTE INC | 70 | 86 | 86 | 72 | 43.2x | 16.0x | 15.3% | 5.8% | 100.0% | 6.9% | 5.2% | 15.1% | 0.0% | 24.0x | $1.8B | VS | |
$OPCH Option Care Health, Inc. | 58 | 51 | 61 | 80 | 27.9x | 20.6x | 14.9% | 5.8% | 19.5% | 6.1% | 3.7% | 16.9% | 0.0% | 86.0x | $4.5B | ||
| SECTOR BENCH | - | - | - | - | - | 23.7x | 11.7x | 5.7% | 2.4% | 64.6% | 4.5% | 2.8% | 8.6% | 0.0% | 0.3x | - | REF |
Option Care Health, Inc. (OPCH) receives a "Hold" rating with a composite score of 57.8/100. It ranks #923 out of 7,333 stocks in our coverage universe and carries a 3-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
Outperforming peers — winners tend to keep winning over 3-12 months
Trading at a discount to fundamentals — favorable entry valuation
Average quality profile
Low volatility — smoother ride and historically better risk-adjusted returns
Moderate investment profile
Mid-range overall rating
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Services sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
Projection based on user-defined inputs. Re-calculated daily against current market data.
Reverse DCF Framework — Mauboussin Methodology
Institutional-grade Reverse DCF analysis. This model identifies the growth hurdles embedded in current market prices. When implied growth is significantly lower than historical or projected rates, a margin of safety may exist. Re-audited daily.
No analyst ratings for OPCH.
View All Ratings| Factor | Global | Sector | Tilt |
|---|---|---|---|
| PROFITABILITY | 51 | 60 | -9DRAG |
| MOMENTUM | 80 | 89 | -9DRAG |
| VALUATION | 61 | 68 | -7DRAG |
| INVESTMENT | 36 | 61 | -25DRAG |
| STABILITY | 91 | 97 | -6DRAG |
| SHORT INT | 26 | 12 | +14ALPHA |
Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.
ROIC 7.5% vs WACC 8.2% (spread -0.7%)
GM 19% vs sector 65%, OM 6% vs sector 5%
Capital turnover 1.68x
Rev growth 17%, 10yr history
Interest coverage 6.0x, Net debt/EBITDA 10.1x
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
We rate Option Care Health, Inc. (OPCH) as a Hold with a composite score of 57.8/100 at a current price of $33.82. The stock presents a mixed quantitative picture — neither compelling enough to warrant new accumulation nor weak enough to justify selling.
Option Care Health, Inc. holds a top-quartile position (#0 of 50) within the Services sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 57.8/100 places it at rank #923 in our full universe.
The near-term outlook is constructive, with revenue growing at 17% and momentum in the 80th percentile confirming positive market sentiment. The combination of strong top-line growth and favorable price dynamics suggests the company is executing well on its growth strategy.
Narrow
Low
Poor
Undervalued
Positive momentum indicates institutional accumulation.
Stable competitive position in a defensive sector.
Vulnerability to macroeconomic shocks and interest rate volatility.
Option Care Health, Inc. represents a hold based on multi-factor quantitative performance.
Our model assigns Option Care Health, Inc. a Hold rating, with a composite score of 57.8/100 and 3 out of 5 stars. Ranked #923 of 7,333 stocks, OPCH presents a mixed quantitative picture — neither compelling enough to initiate new positions nor weak enough to warrant selling. Investors already holding may consider maintaining their position while monitoring for changes in the factor profile.
With a quality score of 51/100, OPCH shows adequate but unremarkable business quality. The company reports a return on equity of 14.9% (sector avg: 5.7%), gross margins of 19.5% (sector avg: 64.6%), net margins of 3.7% (sector avg: 2.8%). This suggests the company generates acceptable returns but may lack the competitive positioning or operational efficiency to stand out from peers.
OPCH's value score of 61/100 indicates the stock is fairly valued based on its current fundamentals. Key valuation metrics include a P/E ratio of 27.92x, an EV/EBITDA of 20.59x, a P/B ratio of 4.17x. At this level, neither a clear bargain nor overpriced, the stock's attractiveness depends more on forward growth expectations and qualitative factors.
Option Care Health, Inc.'s investment score of 36/100 suggests limited reinvestment activity. Key growth metrics include revenue growth of 16.9% vs. a sector average of 8.6% and a return on assets of 5.8% (sector: 2.4%). While this can be positive for mature, cash-generative businesses returning capital to shareholders, it may also signal a lack of growth opportunities or management conservatism.
OPCH shows strong momentum characteristics with a score of 80/100. The stock has been trending above key moving averages, indicating solid demand from institutional buyers. Revenue growth stands at 16.9% year-over-year, while a beta of 0.33 reflects its sensitivity to broader market moves. This level of momentum typically signals sustained investor confidence and favorable near-term price action.
Option Care Health, Inc. earns an excellent stability score of 91/100, reflecting low price volatility and a conservatively managed balance sheet. Key stability metrics include a beta of 0.33 and a debt-to-equity ratio of 86.00x (sector avg: 0.3x). Stocks with this level of stability tend to act as portfolio anchors, providing downside protection during market corrections while still participating in broad market advances.
Option Care Health, Inc.'s short interest score of 26/100 reveals significant bearish positioning, suggesting institutional investors are actively betting against the stock. Specific risk factors include elevated leverage (D/E: 86.00x). At $4.5B (mid-cap), OPCH carries meaningful risk and is best suited for investors with high risk tolerance who have thoroughly evaluated the bear thesis.
Option Care Health, Inc. is a mid-cap company in the Services sector, ranked #0 of 50 in its sector (100th percentile) and #923 of 7,333 overall (87th percentile). Key comparisons include ROE of 14.9% exceeding the 5.7% sector median and operating margins of 6.1% above the 4.5% sector average. This top-quartile standing reflects exceptional competitive strength relative to Services peers.
While OPCH currently exhibits a HOLD profile, superior opportunities exist within the SERVICES sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Services Alpha →Quant Factor Profile
Key factor gap
Stability (91) vs Short Int. (26) — closing this gap could shift the rating.
EV/EBITDA 76% ABOVE SECTOR MEDIAN
ROE 160% ABOVE SECTOR MEDIAN (FAVORABLE)
Gross Margin 70% BELOW SECTOR MEDIAN
Above 50MA
37.18%
Net New Highs
+51081
Option Care Health Inc (OPCH) reports a 13% revenue increase and strategic advancements, while navigating biosimilar impacts and economic pressures.
Alternate site health provider Option Care Health (NASDAQ:OPCH) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 8.8% year on year to $1.47 billion. On the other hand, the company’s full-year revenue guidance of $5.9 billion at the midpoint came in 1.4% below analysts’ estimates. Its non-GAAP profit of $0.46 per share was in line with analysts’ consensus estimates.
BANNOCKBURN, Ill., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Financial Highlights (year-over-year comparisons unless otherwise noted) Net revenue of $1,465.4 million, up 8.8%Net income of $58.5 million, down 2.7%GAAP dilute
Option Care Health (NASDAQ:OPCH) executives said the company delivered 2025 results in line with figures it had pre-announced in January and reaffirmed its 2026 outlook, while continuing to navigate reimbursement and mix headwinds tied to STELARA and biosimilar conversions. Scale, payer programs, a
J.Jill, Option Care Health and Amphenol have been highlighted in this Screen of The Week article.